Drug Therapy Management: An Empirical Report of Drug Therapy Problems, Pharmacists' Interventions, and Results of Pharmacists' Actions

McDonough, Randal P.; Doucette, William R.

doi:10.1331/154434503322226266

Cited by 34 publications

(24 citation statements)

References 48 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Research has shown that pharmacists and medical practitioners working together in patient care results in positive health outcomes in cholesterol reduction (Tsuyuki et al, 2002), hypertension (McLean et al, 2008), heart failure (Gattis, Hasselblad, Whellan, & O'Connor, 1999), depression (Landers, Blenkinsopp, Pollock, & Grime, 2002) and medication management (McDonough & Doucette, 2003). Although multidisciplinary care plans which coordinate and integrate treatment and care processes delivered by different HCPs are well established in hospital and ambulatory care, the ability of HCPs to collaborate in primary care seems to vary between practitioners and practitioner teams (Brock & Doucette, 2004; Van, Krass, & Mitchell, 2007).…”

Section: Introductionmentioning

confidence: 99%

General practitioner–pharmacist interactions in professional pharmacy services

Van

Mitchell

Krass

2011

Journal of Interprofessional Care

View full text Add to dashboard Cite

Australian community pharmacies offer a range of professional pharmacy services (PPS) which include Home Medicines Review (HMR) and the Diabetes Medication Assistance Service (DMAS). The extent of interaction and collaboration between general practitioners (GPs) and pharmacists in the context of these services is unknown. Therefore, the aim of this study was to investigate (1) the nature and extent of interactions between GPs and community pharmacists and; (2) the factors that influence these interactions in the context of PPS. Individual semi-structured face-to-face and telephone interviews were conducted with a purposive sample of 15 GPs and 15 pharmacists in rural and metropolitan areas of New South Wales, Australia. The results indicated that involvement in PPS resulted in a perceived increase in the level of interactions between the pharmacist and GP. Factors found which may influence collaborative behaviour in PPS include interactional, practitioner and environmental determinants. These factors are in line with what has previously been reported however, facilitators of collaboration in the primary care, PPS context included additional environmental factors such as the presence of rules and protocols, interprofessional continuing education and the availability of adequate remuneration. Attention to these environmental factors as well as the more established interactional and practitioner determinants will improve collaboration in PPS.

show abstract

Section: Introductionmentioning

confidence: 99%

General practitioner–pharmacist interactions in professional pharmacy services

Van

Mitchell

Krass

2011

Journal of Interprofessional Care

View full text Add to dashboard Cite

show abstract

“…cholesterol reduction, blood pressure control, medication management. [4][5][6][7][8][9][10][11][12] This has been recognised internationally and has led to a range of initiatives, such as the establishment of pharmacotherapy consultation groups (GPs and community pharmacists) in the Netherlands; making the changes to legislation to allow collaborative practice agreements between physicians and pharmacists in the US; and funding by government of HMRs in Australia. 2,3,13 Inter-professional collaboration is defined as a joint communication and decision-making process using the unique qualities and abilities of all health professionals involved.…”

Section: Introductionmentioning

confidence: 99%

General Practitioner Perceptions of Extended Pharmacy Services and Modes of Collaboration with Pharmacists

Van¹,

Krass²,

Mitchell

2007

Pharmacy Practice and Res

View full text Add to dashboard Cite

Aims:To explore the perceptions of Australian general practitioners (GPs) towards extended pharmacy services, and to investigate the modes and extent of collaboration between community pharmacists and GPs. Method: Semi-structured face-to-face and telephone interviews were conducted on a purposive sample of GPs from Sydney and surrounding areas. The data were thematically analysed, using qualitative data analysis software. Results: 23/68 (34%) GPs approached, agreed to participate in the interviews. The respondents practised in different settings (private/medical centre/specialised settings, rural/suburban/city areas), had been in professional practice for periods ranging from 6 months to several decades and included both female and male practitioners. Support for pharmacist provision of services varied. GP perceptions were mostly positive for home medicines review (HMR), information provision and monitoring. However, most GPs did not favour pharmacists' provision of screening and immunisation services. Most respondents believed that GPpharmacist collaboration would be beneficial to both the patient and the GP. However, despite this, collaboration was minimal in all extended pharmacy services discussed except HMR. Conclusion: HMR is the extended pharmacy service most widely accepted by GPs and has proved to be an effective platform for inter-professional collaboration. Considering the factors that promote effective collaboration in HMR will position us better to improve the GP-pharmacist collaboration crucial for expanding other extended pharmacy services. J Pharm Pract Res 2007; 37: 182-6.

show abstract

“…The number of DTPs (mean of 1.9) that pharmacists identified was toward the lower end of the range reported in prior studies, which have found 0.8 to 4.2 DTPs per patient annually. [16][17][18][19][20][21] However, the study population was taking a large number of medications and had a high prevalence of ADEs relative to the general US population. 22,23 In contrast to prior studies, pharmacists were required to meet with all study patients.…”

Section: Discussionmentioning

confidence: 99%